Managing Pre-clinical Study Data as a Strategic Asset

In this webinar, David Lowis, D. Phil. of Certara, made the case for adopting a solution that allows immediate access, visualization and analysis of pre-clinical data for optimized decision making, while leveraging the FDA mandated CDISC-SEND data standard. Hear how a holistic approach can provide rapid insights that let you anticipate and respond to regulatory questions and accelerate promising programs or stop unproductive ones more quickly so you can get your product to market faster.

Learn More LinkedIn Twitter Facebook Email